BSE Live
Jan 08, 16:01Prev. Close
4091.25
Open Price
4089.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 08, 15:57Prev. Close
4092.20
Open Price
4080.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4026.40 (56)
| Profit & Loss account of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 3,417.69 | 3,228.00 | 2,624.65 | 1,991.49 | 1,683.62 | |
| Less: Excise/Sevice Tax/Other Levies | 7.88 | 7.38 | 7.10 | 4.80 | 3.26 | |
| Revenue From Operations [Net] | 3,409.81 | 3,220.62 | 2,617.55 | 1,986.69 | 1,680.35 | |
| Total Operating Revenues | 3,475.49 | 3,364.87 | 2,766.23 | 2,076.04 | 1,751.73 | |
| Other Income | 305.67 | 35.54 | 131.67 | 135.19 | 58.97 | |
| Total Revenue | 3,781.16 | 3,400.41 | 2,897.90 | 2,211.23 | 1,810.70 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 968.20 | 876.08 | 797.43 | 590.17 | 575.78 | |
| Purchase Of Stock-In Trade | 200.78 | 93.38 | 292.52 | 252.10 | 90.54 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -85.57 | 30.61 | -110.43 | -35.96 | -65.54 | |
| Employee Benefit Expenses | 507.41 | 418.90 | 366.34 | 309.05 | 271.96 | |
| Finance Costs | 172.72 | 58.44 | 36.51 | 39.78 | 39.02 | |
| Depreciation And Amortisation Expenses | 180.22 | 79.47 | 71.50 | 63.90 | 58.13 | |
| Other Expenses | 1,041.32 | 885.21 | 741.22 | 560.29 | 482.92 | |
| Total Expenses | 2,985.08 | 2,442.09 | 2,195.09 | 1,779.33 | 1,452.81 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 796.08 | 958.32 | 702.81 | 431.90 | 357.89 | |
| Exceptional Items | 0.00 | 0.00 | -37.49 | -61.20 | 0.00 | |
| Profit/Loss Before Tax | 796.08 | 958.32 | 665.32 | 370.70 | 357.89 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 165.94 | 205.80 | 126.91 | 58.06 | 68.46 | |
| Less: MAT Credit Entitlement | 134.74 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 141.38 | -9.42 | -6.29 | 1.47 | -0.37 | |
| Tax For Earlier Years | 0.32 | -0.40 | -1.72 | -0.08 | -1.07 | |
| Total Tax Expenses | 172.90 | 195.98 | 118.90 | 59.45 | 67.02 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 623.18 | 762.34 | 546.42 | 311.25 | 290.86 | |
| Profit/Loss From Continuing Operations | 623.18 | 762.34 | 546.42 | 311.25 | 290.86 | |
| Profit/Loss For The Period | 623.18 | 762.34 | 546.42 | 311.25 | 290.86 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 36.83 | 45.05 | 64.58 | 36.79 | 34.38 | |
| Diluted EPS (Rs.) | 36.83 | 45.05 | 64.58 | 36.79 | 34.38 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 237.82 | 227.32 | 198.67 | 193.85 | 175.53 | |
| Indigenous Raw Materials | 589.96 | 513.95 | 484.95 | 315.12 | 318.15 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 6.58 | 6.08 | 2.96 | 2.70 | 1.70 | |
| Indigenous Stores And Spares | 52.99 | 48.83 | 37.28 | 29.25 | 22.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 190.38 | 169.24 | 194.61 | 71.92 | 67.69 | |
| Tax On Dividend | 38.06 | 28.76 | 32.68 | 11.67 | 10.98 | |
| Equity Dividend Rate (%) | 225.00 | 200.00 | 460.00 | 170.00 | 160.00 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012